Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Kerstin Berntorp

Kerstin Berntorp

Adjunct professor

Kerstin Berntorp

Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Author

  • Kerstin Berntorp
  • Anders Frid
  • Ragnar Alm
  • Gunilla Nordin Fredrikson
  • Klas Sjöberg
  • Bodil Ohlsson

Summary, in English

Esophageal dysmotility and gastroparesis are common secondary complications in patients with diabetes mellitus. Patients with dysmotility express antibodies against gonadotropin-releasing hormone (GnRH) in serum. The aim of the present study was to scrutinize patients with diabetes mellitus with regard to the presence of GnRH antibodies, and to examine associations between antibodies and clinical findings.

Department/s

  • Genomics, Diabetes and Endocrinology
  • Department of Clinical Sciences, Malmö
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Internal Medicine - Epidemiology
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2013

Language

English

Publication/Series

BMC Research Notes

Volume

6

Issue

Aug.,17

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Endocrinology and Diabetes
  • Cardiac and Cardiovascular Systems

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 1756-0500